Deutsche Bank Ag\ Relay Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 52,182 shares of RLAY stock, worth $247,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,182

Previous 37,970 37.43%

Holding current value

$247,864

Previous $247,000 49.39%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $88,540 - $135,156	14,212 Added 37.43%	52,182 $369,000
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $80,505 - $109,432	-13,645 Reduced 26.44%	37,970 $247,000
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $9,360 - $15,063	1,248 Added 2.48%	51,615 $428,000
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $8,486 - $16,209	-1,412 Reduced 2.73%	50,367 $554,000
Q3 2023 Nov 09, 2023	BUY	$8.24 - $12.97 $50,420 - $79,363	6,119 Added 13.4%	51,779 $435,000
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $1.12 Million - $2.04 Million	-111,683 Reduced 70.98%	45,660 $573,000
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $1.19 Million - $1.81 Million	-79,621 Reduced 33.6%	157,343 $2.59 Million
Q4 2022 Feb 13, 2023	SELL	$14.16 - $24.02 $2.17 Million - $3.68 Million	-153,144 Reduced 39.26%	236,964 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $4.17 Million - $7.25 Million	230,993 Added 145.17%	390,108 $8.73 Million
Q2 2022 Aug 11, 2022	BUY	$13.31 - $34.88 $816,382 - $2.14 Million	61,336 Added 62.73%	159,115 $2.67 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $49,414 - $78,926	-2,439 Reduced 2.43%	97,779 $2.93 Million
Q4 2021 Feb 11, 2022	BUY	$26.0 - $37.03 $1.49 Million - $2.13 Million	57,417 Added 134.15%	100,218 $3.08 Million
Q3 2021 Nov 04, 2021	BUY	$29.75 - $37.99 $116,382 - $148,616	3,912 Added 10.06%	42,801 $1.35 Million
Q2 2021 Aug 11, 2021	BUY	$27.5 - $38.19 $196,460 - $272,829	7,144 Added 22.5%	38,889 $1.42 Million
Q1 2021 May 13, 2021	BUY	$32.52 - $61.53 $214,892 - $406,590	6,608 Added 26.29%	31,745 $1.1 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $281,310 - $428,025	7,922 Added 46.02%	25,137 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$32.81 - $45.1 $564,824 - $776,396	17,215 New	17,215 $733,000

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $571M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account